Drawing for AESKU.GROUP WE TAKE CARE OF YOUR HEALTH

USPTO serial 79190661

AESKU.GROUP WE TAKE CARE OF YOUR HEALTH

Reviewed by CopyMark Law Group

Reg. 5382826Status 404
Filing date
Status date
Registration date
Jan 23, 2018
Examiner
GALAN, MATTHEW
Law office
Historical data usage

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AESKU.GROUP WE TAKE CARE OF YOUR HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ralph G. Fischer

Buchanan Ingersoll & Rooney PCUnion Trust Building 501 Grant Street,Pittsburgh, PA 15219US

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations, including recombinant proteins, for laboratory analysis and scientific purposes in the field of serology of infectious diseases, autoimmune diseases and allergies; biological preparations, including recombinant proteins, for use in cell cultures other than for medical or veterinary use, in the field of serology of infectious diseases, autoimmune diseases and allergies; enzymes for industrial and scientific purposes; enzyme preparations for industrial and scientific purposesSECTION 70 - CANCELLED—
005Chemical preparations for medical sanitary purposes for the treatment of infectious diseases, autoimmune diseases and allergies and biological preparations for the treatment of infectious diseases, autoimmune diseases and allergies; diagnostic preparations for medical purposes for use in serology in diagnosing infectious diseases, autoimmune diseases and allergies; enzymes and enzyme preparations for medical purposes for use in serology in diagnosing infectious diseases, autoimmune diseases and allergies; in-vitro diagnostic preparations for medical purposes for use in serology in diagnosing infectious diseases, autoimmune diseases and allergies; test strips for use in serology for detection of antibodies in a patient's blood for diagnosing infectious diseases, autoimmune diseases and allergies; chemical and biological reagents, including point of care chemical and biological reagents, for use in serologic diagnostic tests for medical purposes, namely, for diagnosing infectious diseases, autoimmune diseases and allergiesSECTION 70 - CANCELLED—
010Medical apparatus and instruments for laboratory use in analyzing a patient's blood for in vitro diagnostics of infectious diseases, autoimmune diseases and allergies; medical apparatus for analyzing a patient's blood for detecting infectious diseases, autoimmune diseases and allergies; diagnostic apparatus for medical purposes for use in laboratories, hospitals and medical offices in the field of in vitro serologic diagnostics of infectious diseases, autoimmune diseases and allergiesSECTION 70 - CANCELLED—
042Design and development of computer softwareSECTION 70 - CANCELLED—
044Medical assistance; medical services; veterinary services; medical analysis in connection with the treatment of individuals, namely, behavioral analysis for medical purposes, medical analysis of a patient's blood for detecting infectious diseases, autoimmune diseases and allergies; pharmaceutical consultancySECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 3, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 17, 2024NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jul 17, 2024C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jul 12, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 30, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
Jan 23, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 27, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 25, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 13, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 6, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 25, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 25, 2018FIMPFINAL DISPOSITION PROCESSED—
Apr 23, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 23, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 7, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 18, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 3, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 2, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 2, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Oct 2, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 2, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 2, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 16, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 16, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 16, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 23, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 23, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 15, 2017ALIEASSIGNED TO LIE—
Mar 2, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2016RFNTREFUSAL PROCESSED BY IB—
Sep 3, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 2, 2016RFRRREFUSAL PROCESSED BY MPU—
Sep 2, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 1, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 26, 2016DOCKASSIGNED TO EXAMINER—
Aug 26, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance